{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:56:40Z","timestamp":1791161800367,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AG037637-03"],"award-info":[{"award-number":["AG037637-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Aging","award":["T32 AG021890"],"award-info":[{"award-number":["T32 AG021890"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.neurobiolaging.2013.12.006","type":"journal-article","created":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T16:45:13Z","timestamp":1387039513000},"page":"1233-1242","source":"Crossref","is-referenced-by-count":72,"title":["Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology"],"prefix":"10.1016","volume":"35","author":[{"given":"Miranda E.","family":"Orr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Buffenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Oddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s004010100423","article-title":"Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease","volume":"103","author":"Augustinack","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib2","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/j.1460-2075.1992.tb05426.x","article-title":"Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation","volume":"11","author":"Backer","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neulet.2012.04.022","article-title":"Chronic peripheral hyperinsulinemia has no substantial influence on tau phosphorylation in\u00a0vivo","volume":"516","author":"Becker","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbadis.2004.08.014","article-title":"Tau, tangles, and Alzheimer's disease","volume":"1739","author":"Binder","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2012-120571","article-title":"Amyloid-beta and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model","volume":"32","author":"Bitel","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/acel.12057","article-title":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies","volume":"12","author":"Caccamo","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib8","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib9","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1074\/jbc.M110.180638","article-title":"Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism","volume":"286","author":"Caccamo","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib10","doi-asserted-by":"crossref","first-page":"36275","DOI":"10.1074\/jbc.M703561200","article-title":"Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease","volume":"282","author":"Cao","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib11","doi-asserted-by":"crossref","first-page":"23331","DOI":"10.1074\/jbc.M113.463984","article-title":"An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease","volume":"288","author":"Cavallini","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejphar.2013.08.008","article-title":"Insulin, cognition, and dementia","volume":"719","author":"Cholerton","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib13","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Choo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib14","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib15","doi-asserted-by":"crossref","first-page":"12396","DOI":"10.1523\/JNEUROSCI.6189-11.2012","article-title":"Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Straussler-Scheinker disease","volume":"32","author":"Cortes","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib16","doi-asserted-by":"crossref","first-page":"e32792","DOI":"10.1371\/journal.pone.0032792","article-title":"Mechanisms underlying insulin deficiency-induced acceleration of beta-amyloidosis in a mouse model of Alzheimer's disease","volume":"7","author":"Devi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cmet.2013.02.008","article-title":"Duration of rapamycin treatment has differential effects on metabolism in mice","volume":"17","author":"Fang","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jnc.12285","article-title":"Cleavage of GSK-3beta by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3beta activity induced by H2O2","volume":"126","author":"Feng","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib20","doi-asserted-by":"crossref","first-page":"E1373","DOI":"10.1152\/ajpendo.00500.2011","article-title":"Increased abeta production prompts the onset of glucose intolerance and insulin resistance","volume":"302","author":"Jimenez-Palomares","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.expneurol.2009.11.005","article-title":"Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice","volume":"223","author":"Jolivalt","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib22","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/jnr.21787","article-title":"Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin","volume":"86","author":"Jolivalt","year":"2008","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-2009-0973","article-title":"Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes","volume":"16","author":"Jones","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib24","doi-asserted-by":"crossref","first-page":"e7917","DOI":"10.1371\/journal.pone.0007917","article-title":"Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease","volume":"4","author":"Ke","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cmet.2013.08.002","article-title":"A\u00a0central role for mTOR in lipid homeostasis","volume":"18","author":"Lamming","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/acel.12097","article-title":"Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive","volume":"12","author":"Lamming","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib27","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/371423a0","article-title":"A\u00a0brain-specific activator of cyclin-dependent kinase 5","volume":"371","author":"Lew","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1471-4159.2009.06320.x","article-title":"Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease","volume":"111","author":"Liu","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1474-9726.2011.00791.x","article-title":"Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling","volume":"11","author":"Majumder","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib31","doi-asserted-by":"crossref","first-page":"e25416","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib32","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00109-013-1057-6","article-title":"mTOR and regulation of energy homeostasis in humans","volume":"91","author":"Mannaa","year":"2013","journal-title":"J.\u00a0Mol. Med. (Berl)"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer's disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006239","article-title":"Epidemiology of Alzheimer disease","volume":"2","author":"Mayeux","year":"2012","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1750-3639.2010.00430.x","article-title":"Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity","volume":"21","author":"Medina","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib36","doi-asserted-by":"crossref","first-page":"10350","DOI":"10.1073\/pnas.89.21.10350","article-title":"IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85","volume":"89","author":"Myers","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2741\/s310","article-title":"The role of mTOR signaling in Alzheimer disease","volume":"4","author":"Oddo","year":"2012","journal-title":"Front Biosci. (Schol Ed.)"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2007.04607.x","article-title":"Genetically augmenting tau levels does not modulate the onset or progression of abeta pathology in transgenic mice","volume":"102","author":"Oddo","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib40","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1523\/JNEUROSCI.2464-08.2008","article-title":"Blocking abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between abeta and tau pathology","volume":"28","author":"Oddo","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib41","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib42","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/j.1582-4934.2008.00509.x","article-title":"mTOR-dependent signalling in Alzheimer's disease","volume":"12","author":"Pei","year":"2008","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-2010-1270","article-title":"Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 abetaPP-overexpressing mice","volume":"19","author":"Plaschke","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib46","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4161\/cc.10.20.17886","article-title":"Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation?","volume":"10","author":"Saha","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib47","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib48","doi-asserted-by":"crossref","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"issue":"Pt 3","key":"10.1016\/j.neurobiolaging.2013.12.006_bib49","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj3030701","article-title":"Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation","volume":"303","author":"Stambolic","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib51","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and abeta deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib52","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib53","doi-asserted-by":"crossref","first-page":"26897","DOI":"10.1074\/jbc.270.45.26897","article-title":"An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator","volume":"270","author":"Tang","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib54","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.coph.2009.07.004","article-title":"Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation","volume":"9","author":"Tanti","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib55","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/371419a0","article-title":"p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib56","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/en.2003-1522","article-title":"Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells","volume":"145","author":"Ubeda","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1744-8069-7-49","article-title":"Resveratrol inhibits Cdk5 activity through regulation of p35 expression","volume":"7","author":"Utreras","year":"2011","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib58","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1475-2840-11-155","article-title":"The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy","volume":"11","author":"Ye","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib60","doi-asserted-by":"crossref","first-page":"e6189","DOI":"10.1371\/journal.pone.0006189","article-title":"Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.12.006_bib61","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1017\/S1461145711000915","article-title":"Increased Cdk5\/p35 activity in the dentate gyrus mediates depressive-like behaviour in rats","volume":"15","author":"Zhu","year":"2012","journal-title":"The Int. J. Neuropsychopharmacol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013006313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013006313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T23:04:43Z","timestamp":1564959883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013006313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0197458013006313"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.12.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}